Back to News
Market Impact: 0.4

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

HQY
Company FundamentalsAnalyst EstimatesAnalyst InsightsCorporate EarningsMarket Technicals & FlowsInvestor Sentiment & PositioningHealthcare & Biotech
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

The article details Zacks' proprietary investment methodology, combining its Zacks Rank with Style Scores (Value, Growth, Momentum, and a composite VGM) to identify high-potential stocks. HealthEquity (HQY), a healthcare account management provider, is highlighted as a notable growth prospect. Despite holding a #3 (Hold) Zacks Rank, HQY exhibits strong fundamentals with an 'A' VGM Score and an 'A' Growth Style Score, supported by a projected 22.1% year-over-year earnings growth and recent upward revisions to its fiscal 2026 earnings consensus to $3.81 per share, positioning it as a compelling consideration for growth-focused investors.

Analysis

HealthEquity (HQY) exhibits a strong growth profile, as highlighted by its 'A' rating in both the Zacks Growth Style Score and the composite VGM Score. This positive assessment is substantiated by a forecasted year-over-year earnings growth of 22.1% for the current fiscal year. Further bolstering this outlook, analyst sentiment appears to be improving, with three upward earnings estimate revisions for fiscal 2026 occurring in the last 60 days. These revisions have lifted the Zacks Consensus Estimate for that period by $0.08 to $3.81 per share. While the stock carries a neutral Zacks Rank of #3 (Hold), its consistent ability to outperform expectations is notable, evidenced by an average earnings surprise of +11.1%. The combination of these quantitative metrics suggests that despite the neutral top-line rating, the underlying fundamental momentum and growth trajectory for the healthcare account management provider are significant.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo